Publications by authors named "Kato Rans"

Claim this Profile
U
Using machine learning to predict patient-reported symptom clusters in prostate cancer patients receiving radiotherapy.
Elke Rammant, Emile Deman, Valérie Fonteyne, Lindsay Poppe, Renée Bultijnck, Kato Rans

Health Qual Life Outcomes· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of stereotactic photon and proton treatment plans for metastasis-directed radiotherapy.
Rans Kato, De Roover Robin, De Meerleer Gert, Haustermans Karin, Berghen Charlien

Phys Imaging Radiat Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moderately hypofractionated radiotherapy for prostate cancer in an era of SBRT and focal boosting.
Gert De Meerleer, Kato Rans

Lancet Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of progression-directed therapy on survival in metastatic castration-refractory prostate cancer: MEDCARE phase 3 trial.
Kato Rans, Karolien Goffin, Steven Joniau, Gedske Daugaard, Julie den Hartog

BJU Int· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progression-directed Therapy in Oligoprogressive Castration-resistant Prostate Cancer: Final Results from the Prospective, Single-arm, Phase 2 MEDCARE Trial.
Kato Rans, Steven Joniau, Charlien Berghen, Karolien Goffin, Herlinde Dumez

Eur Urol Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oligometastatic Recurrent Prostate Cancer: Whether To Intensify Treatment or Not.
Gert De Meerleer, Steven Joniau, Jan Benijts, Kato Rans

Eur Urol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage vesiculectomy for local prostate cancer recurrence: surgical technique and early post-operative outcomes.
Alexander Giesen, Thomas Van den Broeck, Dries Develtere, Yannic Raskin, Kevin Wymer, Kato Rans

World J Urol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Use of Soy Isoflavones in the Treatment of Prostate Cancer: A Focus on the Cellular Effects.
Hans Van der Eecken, Steven Joniau, Charlien Berghen, Kato Rans, Gert De Meerleer

Nutrients· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dosimetric and Hematologic Implications of Prostate-Only Versus Whole Pelvic Radiotherapy: Results of the Multicentric Phase 3 PROPER Study.
Valérie Fonteyne, Willeke Danckaert, Piet Ost, Charlien Berghen, Katrien Vandecasteele, Kato Rans

Technol Cancer Res Treat· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SPARKLE: a new spark in treating oligorecurrent prostate cancer: adding systemic treatment to stereotactic body radiotherapy or metastasectomy: key to long-lasting event-free survival?
Kato Rans, Berghen Charlien, Ameye Filip, De Hertogh Olivier, den Hartog Julie

BMC Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Another Step Towards the Acceptance of Metastasis-directed Therapy in Low-volume Metastatic Prostate Cancer.
Gert De Meerleer, Kato Rans, Steven Joniau, Charlien Berghen

Eur Urol Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elective nodal radiotherapy in prostate cancer.
Gert De Meerleer, Charlien Berghen, Alberto Briganti, Christof Vulsteke, Julia Murray, Kato Rans

Lancet Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Regard to Zelefsky et al.
Kato Rans, Gert De Meerleer, Steven Joniau, Adinda Baten, Patrick Berkovic

Int J Radiat Oncol Biol Phys· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long- versus short-term androgen deprivation therapy with high-dose radiotherapy for biochemical failure after radical prostatectomy: a randomized controlled trial.
Charlien Berghen, Steven Joniau, Annouschka Laenen, Gaetan Devos, Kato Rans

Future Oncol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastasis-directed therapy in castration-refractory prostate cancer (MEDCARE): a non-randomized phase 2 trial.
Charlien Berghen, Steven Joniau, Kato Rans, Gaëtan Devos, Kenneth Poels

BMC Cancer· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastasis-directed therapy for oligometastatic urological tumours: still no second-hand news.
Charlien Berghen, Steven Joniau, Christof Vulsteke, Maarten Albersen, Gaëtan Devos, Kato Rans

Ecancermedicalscience· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis